Back to top
more

Owens & Minor (OMI)

(Real Time Quote from BATS)

$6.43 USD

6.43
419,572

-0.08 (-1.23%)

Updated Aug 6, 2025 12:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (148 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Are Investors Undervaluing Owens & Minor (OMI) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Zacks.com featured highlights include: ArcBest, American Airlines, AmerisourceBergen, Owens & Minor and Commercial Metals

by Zacks Equity Research

Zacks.com featured highlights include: ArcBest, American Airlines, AmerisourceBergen, Owens & Minor and Commercial Metals

Zacks Equity Research

Zacks.com featured highlights include: Delta Air Lines, Costco Wholesale, Owens & Minor, EOG Resources and JELD-WEN

by Zacks Equity Research

Zacks.com featured highlights include: Delta Air Lines, Costco Wholesale, Owens & Minor, EOG Resources and JELD-WEN

Maharathi Basu headshot

5 Stocks That Look Impressive After Broker Rating Upgrades

by Maharathi Basu

The guidance to design a winning portfolio comes from brokers. Given their thorough know-how pertaining to the stock market, investors often look to be guided by broker advice.

Swayta Shah headshot

Buy These 5 Top-Ranked Stocks With Upgraded Broker Ratings

by Swayta Shah

After an in-depth research, brokers decide to rate a company's stock. Thus, when they upgrade a stock, you can easily rely on it.

Nitish Marwah headshot

New Strong Buy Stocks for November 7th

by Nitish Marwah

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Zacks Equity Research

Owens & Minor (OMI) Tops Q3 Earnings Estimates

by Zacks Equity Research

Owens & Minor (OMI) delivered earnings and revenue surprises of 15.79% and -1.62%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here's Why You Should Add ResMed (RMD) to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about ResMed's (RMD) performance.

Zacks Equity Research

Myriad Genetics Test to Identify Cancer Patients Gets FDA Nod

by Zacks Equity Research

Myriad Genetics (MYGN) moves a step toward advanced treatment by identifying women with ovarian cancer, who are currently receiving chemotherapy.

Zacks Equity Research

LabCorp (LH) Q3 Earnings Surpass Estimates, Tapers View

by Zacks Equity Research

LabCorp (LH) impresses investors with third-quarter 2019 results on the robust performance of the Covance Drug Development segment.

Zacks Equity Research

Boston Scientific (BSX) Catches Eye: Stock Jumps 5%

by Zacks Equity Research

Boston Scientific (BSX) saw a big move last session, as its shares jumped 5% on the day, amid huge volumes.

Zacks Equity Research

Earnings Preview: Owens & Minor (OMI) Q3 Earnings Expected to Decline

by Zacks Equity Research

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here's Why You Should Hold on to Abbott (ABT) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Abbott's (ABT) performance.

Zacks Equity Research

ResMed Upgrades Nasal Care by Introducing Cradle CPAP Mask

by Zacks Equity Research

ResMed (RMD) revolutionizes sleep apnea treatment by introducing a hassle-free and easy-to-use mask.

Zacks Equity Research

Owens & Minor, Acuity Brands, Tesla, Ford and General Motors highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Owens & Minor, Acuity Brands, Tesla, Ford and General Motors highlighted as Zacks Bull and Bear of the Day

Brian Bolan headshot

Bull Of The Day: Owens and Minor (OMI)

by Brian Bolan

This stock has been on a run of late and it looks like it won't stop until after it makes it to double digits.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for October 21st

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 21st

Zacks Equity Research

Will Owens & Minor Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor Owens & Minor.

Zacks Equity Research

Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about IDEXX's (IDXX) performance.

Zacks Equity Research

Abbott Forms Alliance With Omada Health for Diabetes Care

by Zacks Equity Research

Abbott (ABT) collaborates with Omada Health to revolutionize diabetes care by expanding technological access.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for October 11th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday

Zacks Equity Research

Is Owens & Minor (OMI) a Suitable Stock for Value Investors?

by Zacks Equity Research

Let's see if Owens & Minor, Inc. (OMI) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

Zacks Equity Research

Owens & Minor (OMI) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Owens & Minor (OMI) delivered earnings and revenue surprises of 42.86% and 2.35%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.